Enara Bio raised $32.5m in Series B funding co-led by Pfizer Ventures and M Ventures, joined by RA Capital, Samsara BioCapital, and SV Health Investors.

Biotech Health services Pharma

Investments

03 September 2024

Enara Bio (company)

Biotech Health services Pharma

Total investments received (USD): 50m

Round value (USD): 32.5m

Round investors: Merck Ventures Pfizer Venture Investments RA Capital Management SV Health Investors Samsara BioCapital

Industry: Biotech Health services Pharma

Biotech Health services

Investments 02 March 2025

AI (big data) Biotech Health services Software Services

Investments 03 February 2025

Biotech Competitive Intelligence Health services Software Services

Investments 21 December 2024

Biotech Health services Pharma

Investments 15 October 2024

Biotech Health services Manufacturing Pharma

Investments 02 October 2024